WOMAC Osteoarthritis Index Template

Key Takeaways

WOMAC measures three dimensions of knee and hip osteoarthritis: pain (5 items), stiffness (2 items), and physical function (17 items) on a 24-item self-administered questionnaire.

The WOMAC osteoarthritis index is free to use clinically, though it’s a registered trademark; use validated scoring methods to ensure accurate patient tracking.

Minimum clinically important difference (MCID) thresholds help clinicians interpret whether treatment changes represent true functional improvement for individual patients.

Pabau’s digital forms and outcomes tracking features enable automated WOMAC documentation and longitudinal progress monitoring within patient records.

Download Your Free WOMAC Osteoarthritis Index Template

What is the WOMAC Osteoarthritis Index Template?

The WOMAC osteoarthritis index template is a clinically validated, self-administered questionnaire that has become the gold standard for assessing hip and knee osteoarthritis across musculoskeletal practice. Developed in 1982 by researchers from Western Ontario and McMaster Universities, the tool measures three core dimensions of osteoarthritis impact: pain severity, joint stiffness, and physical functional limitations.

WOMAC is a registered trademark (CDN No. TMA 545,986; EU No. 004885235; USA No. 3520667) owned by its original developers. However, the questionnaire is free to use in clinical practice without licensing fees. Version 3.1 (WOMAC LK 3.1) is the current standard, available in multiple formats including Likert scale, visual analogue scale (VAS), and numeric rating scale (NRS) versions depending on practitioner preference and patient capability.

The questionnaire serves multiple clinical purposes: baseline functional assessment before intervention, outcome tracking post-treatment (particularly following total knee arthroplasty or total hip arthroplasty), therapy effectiveness evaluation, and research participation documentation. The American Physical Therapy Association (APTA) recognises WOMAC as a core outcome measure for osteoarthritis management across physiotherapy settings.

How to Use the WOMAC Osteoarthritis Index Template

Using the WOMAC osteoarthritis index template in clinical practice involves five structured steps that integrate seamlessly into patient workflows and documentation systems.

1. Initial Administration: Provide the WOMAC questionnaire to the patient at their first appointment or during initial assessment. Explain that they’re rating their knee or hip symptoms over the past 48 hours. For patients aged 65+, offer large-print versions or read the questions aloud if literacy or vision limitations exist. Record the administration date in the patient record.
2. Pain Subscale Completion (5 items): The patient rates pain intensity for walking on flat surfaces, stairs, at night, sitting, and standing using the selected scale (Likert 0-4, VAS 0-100, or NRS 0-10). This subscale captures pain frequency and severity across functional contexts most relevant to daily living.
3. Stiffness Subscale (2 items): The patient reports morning stiffness and stiffness after sitting/resting using the same scale. Joint stiffness duration correlates with inflammatory markers and influences therapy progression, making this subscale critical for tracking inflammation changes.
4. Physical Function Subscale (17 items): This largest section covers 17 activities of daily living and instrumental activities (stairs, standing, walking distances, bathing, getting in/out of a car, shopping, household tasks). Item responses reflect functional capacity limitations that most directly impact patient quality of life and discharge planning decisions.
5. Scoring and Documentation: Calculate subscale totals by summing item scores (Likert method: pain 0-20, stiffness 0-8, function 0-68; total 0-96). Document the total and subscale scores in the patient record with the assessment date. Use digital forms to automate WOMAC data capture and eliminate manual scoring errors.

WOMAC Subscales Breakdown

Understanding each WOMAC subscale’s clinical significance helps physiotherapists, osteopaths, and musculoskeletal practitioners interpret results accurately and prioritise treatment targets.

Scoring and Interpreting WOMAC Results

WOMAC scoring methodology is straightforward but requires attention to scale format and population-specific interpretation thresholds.

Likert Scale Scoring: Each item is rated 0 (none) to 4 (extreme), yielding subscale totals for pain (0-20), stiffness (0-8), and physical function (0-68), with a total WOMAC score of 0-96. Higher scores always indicate worse symptoms and greater functional limitations. For VAS formats, convert 0-100 millimetre responses proportionally.

Minimum clinically important difference (MCID) thresholds help clinicians determine whether observed score changes reflect real clinical improvement. Research published in BMC Musculoskeletal Disorders identifies MCID values for total knee replacement patients: approximately 12-13 points on the WOMAC total score represents meaningful functional recovery. Pain subscale MCID is roughly 4 points, and physical function MCID is 7-9 points, though these vary slightly by patient population (pre-arthroplasty vs. post-operative).

Document baseline WOMAC scores at initial assessment, repeat measurement at mid-treatment intervals (typically 4-6 weeks), and final assessment post-discharge. Comparing scores against MCID thresholds informs clinical decisions about treatment intensity, patient counselling regarding prognosis, and discharge readiness. A patient whose baseline WOMAC total is 72 who improves to 58 post-treatment has surpassed the MCID threshold (14-point improvement > 12-point MCID), signalling clinically meaningful functional recovery.

Who Benefits from the WOMAC Osteoarthritis Index?

WOMAC application spans multiple healthcare settings and professional roles wherever osteoarthritis management occurs.

• Physiotherapy clinics: Using WOMAC for pre- and post-operative tracking in total knee replacement (TKR) and total hip replacement (THR) pathways; measuring conservative therapy outcomes in early-stage osteoarthritis.
• Musculoskeletal medicine and sports medicine practices: Assessing functional capacity in knee and hip osteoarthritis to guide exercise prescription intensity and activity modification counselling.
• Osteopathic and chiropractic clinics: Documenting baseline pain and function pre-treatment and monitoring improvement trajectories across treatment episodes.
• Integrated care pathways (UK NHS): Incorporating WOMAC into shared care agreements for osteoarthritis management between primary care GPs and secondary care orthopaedic surgeons.
• Research cohorts: Enabling standardised data collection for osteoarthritis epidemiology, intervention trials, and long-term outcome studies (WOMAC has been validated in Persian, Italian, and multiple other languages).

Clinical Benefits of Standardised WOMAC Assessment

Adopting WOMAC as a routine outcome measure strengthens clinical documentation, enhances evidence-based decision-making, and supports patient communication about functional progress.

Documentation clarity: Standardised items eliminate vague subjective language like “patient reports improved knee” and replace it with measurable data. WOMAC scores create objective records suitable for regulatory audits, insurance verification, and medico-legal protection.

Treatment responsiveness: Subscale tracking reveals whether interventions address pain, stiffness, or function selectively. A patient whose pain improves but function remains limited signals need for functional training emphasis; conversely, improving function despite persistent pain suggests pain management inadequacy.

Patient engagement: Reviewing WOMAC progress data with patients demonstrates tangible functional gains, increasing motivation and adherence. The familiarity of WOMAC items (stairs, walking, daily activities) helps patients recognise real-world improvements.

Compliance support: WOMAC data supports quality improvement initiatives and compliance reporting for CQC inspections (UK context). NICE guidelines for osteoarthritis management recommend outcome measure documentation, and WOMAC fulfils this requirement with established measurement properties.

Comparing WOMAC to Related Outcome Measures

Several comparable outcome measures exist for osteoarthritis and joint function assessment. WOMAC remains most widely used for hip and knee OA; the RehabMeasures Database (Shirley Ryan AbilityLab) documents WOMAC as the most frequently cited outcome measure in musculoskeletal research.

KOOS (Knee Injury and Osteoarthritis Outcome Score) expands WOMAC with additional domains (symptoms, ADL, sport/recreation, quality of life) for younger, more active patients. HOOS (Hip Disability and Osteoarthritis Outcome Score) applies similar expansion to hip conditions. Forgotten Joint Score-12 (FJS-12) measures joint awareness post-arthroplasty with higher sensitivity to excellent functional outcomes. For hand osteoarthritis, AUSCAN remains the standard. Clinicians select WOMAC when core pain, stiffness, and function domains suffice; longer measures when granular sport/recreation or quality-of-life data drives treatment decisions.

Implementing WOMAC in Your Practice Workflow

Successful WOMAC integration requires minimal effort when embedded into intake and discharge routines. Print or digitally deliver the questionnaire at first appointment with written instructions (reading time: 5-10 minutes). Automated documentation tools eliminate manual data entry; digital forms calculate subscale totals automatically and flag clinically meaningful changes. Schedule repeat WOMAC administration at standard intervals (4-week, 8-week, discharge) aligned with your treatment episodes. Teach staff to interpret MCID thresholds so they recognise when improvement becomes clinically significant.

Store WOMAC baseline and follow-up scores chronologically in patient records, visible to all practitioners on the team. Train physiotherapists to reference WOMAC trends during patient consultations, tying score improvements to observable functional gains (e.g., “Your pain score dropped from 18 to 10, reflecting your improved tolerance for stairs and walking distances”). This transparency builds patient confidence and justifies ongoing treatment intensity.

Regulatory and Proprietary Considerations

WOMAC carries registered trademark status across multiple jurisdictions. Clinical use is royalty-free; no licensing fee applies to patient assessment or treatment documentation. However, WOMAC cannot be modified, republished, or sold without explicit permission from trademark holders. Use the validated version 3.1 from official sources (WOMAC.com user guide) to ensure measurement property consistency.

Research use of WOMAC data requires citation of original developers and acknowledgment of trademark status. If conducting your own outcome studies, register your research with relevant ethics boards and follow WOMAC user guidelines available at womac.com.

Frequently Asked Questions